Saturday 17 October 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024. In the quarter to June 2026, revenue fell 1.92%, EPS grew 14.0% and free cash flow grew 58.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

533.12 8.39 −1.55%

Follow UTHR

Alert me

Market cap: $23.2B
P/E: 17.6×
Fwd P/E: 20.1×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	20.04%	19.71%	20.26%	19.32%
Piotroski F-Score Full definition →		8	8	7	6
ROA Full definition →		17.57%	17.51%	17.81%	17.33%
ROIC Full definition →		24.42%	22.34%	23.94%	23.44%
Return on Tangible Assets Full definition →		28.24%	27.40%	31.30%	27.28%
Average Days of Receivables Full definition →		34.73	40.16	35.93	35.90
Free Cash Flow per Share Full definition →		25.37	23.37	23.38	25.66
Free Cash Flow Full definition →		1,111.20	1,035.20	1,016.90	1,093.00
Capital Expenditures Full definition →		(445.00)	(526.00)	(546.40)	(592.20)
Other line items
Cash ROIC Full definition →		11.87%	10.33%	12.62%	12.06%
Accounts Receivable Turnover Full definition →		9.78	10.11	10.00	9.15
Accounts Payable Turnover Full definition →		0.86	0.92	0.98	0.94
Inventory Turnover Full definition →		2.21	2.25	2.47	2.41
Average Days of Payables Full definition →		478.62	463.37	427.65	415.59
Days of Inventory on Hand Full definition →		180.51	173.86	153.02	161.80
Tax Rate Full definition →		(0.24)	(0.22)	(0.20)	(0.17)
Research and Development Expense of Revenue Full definition →		17.40%	17.28%	17.01%	17.48%
Selling, General and Administrative Expense of Revenue Full definition →		23.45%	23.75%	24.29%	24.22%
Share Based Compensation of Revenue Full definition →		4.34%	4.64%	4.73%	4.93%
Interest Coverage Full definition →		61.46	76.54	87.53	116.82
Operating CF/Net income Full definition →		1.22	1.17	1.21	1.29
Depreciation/Fixed assets Full definition →		0.05	0.05	0.05	0.05
Capex/Depreciation Full definition →		(5.39)	(6.14)	(6.18)	(6.47)
Revenue per Share Full definition →		71.42	71.84	72.87	74.05
Operating CF per Share Full definition →		35.53	35.24	35.94	39.56
Capex per Share Full definition →		(10.16)	(11.87)	(12.56)	(13.90)
Capex to Sales Full definition →		0.14	0.17	0.17	0.19

Show all line items

Columns are period end dates

Stockrow Weekly